Insider Transactions in Q4 2025 at Praxis Precision Medicines, Inc. (PRAX)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 20
2025
|
Lauren Mastrocola Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
13,600
-32.35%
|
$2,611,200
$192.34 P/Share
|
|
Nov 20
2025
|
Lauren Mastrocola Principal Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,600
+9.6%
|
$884,000
$65.16 P/Share
|
|
Nov 20
2025
|
Alex Nemiroff General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
25,130
-16.86%
|
$4,824,960
$192.73 P/Share
|
|
Nov 20
2025
|
Alex Nemiroff General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
25,130
+12.38%
|
$1,809,360
$72.65 P/Share
|
|
Nov 14
2025
|
Timothy Edwin Kelly Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
384
+1.53%
|
$11,904
$31.62 P/Share
|
|
Oct 16
2025
|
Adage Capital Management, L.P. > 10% Shareholder |
BUY
Open market or private sale
|
Indirect |
301,310
+1.45%
|
$34,048,030
$113.6 P/Share
|
|
Oct 16
2025
|
Adage Capital Management, L.P. > 10% Shareholder |
BUY
Open market or private sale
|
Indirect |
12,600
+0.53%
|
$1,134,000
$90.0 P/Share
|